Literature DB >> 8098051

Drug interactions with antipsychotic agents.

D C Goff1, R J Baldessarini.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8098051

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  8 in total

1.  Huntington's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 2.  Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.

Authors:  W W Fleischhacker; M Hummer
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

3.  Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol.

Authors:  J G Shin; K Kane; D A Flockhart
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

Review 4.  Clinically significant interactions of psychotropic agents with antipsychotic drugs.

Authors:  M C Meyer; R J Baldessarini; D C Goff; F Centorrino
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

Review 5.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 6.  Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness.

Authors:  R Eilers
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

7.  Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients--a prescription database study.

Authors:  J U Rosholm; J Hallas; L F Gram
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 8.  Pharmacokinetic optimisation of the treatment of psychosis.

Authors:  A E Balant-Gorgia; L P Balant; A Andreoli
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.